key: cord-0849524-s7439f7k
authors: BAULOS, P. D.; Tom, M. A.
title: POS-845 URINALYSIS PROFILE AND OUTCOMES OF PATIENTS WITH COVID-19 ADMITTED AT SOUTHERN PHILIPPINES MEDICAL CENTER
date: 2022-02-28
journal: Kidney International Reports
DOI: 10.1016/j.ekir.2022.01.883
sha: 7480a4a9598211bfbb1bc5d128b4834ad891b770
doc_id: 849524
cord_uid: s7439f7k

nan

experienced similar severe clinical presentation of Category 4 and 5. Unresolved AKI group had statistically significant higher urea and creatinine level. Unresolved AKI patients had lower albumin. They had increased level of inflammatory marker CRP and prothrombotic marker, D-dimer. However, this was not statistically significant. The unresolved AKI group underwent more kidney replacement therapy n=4(23.5%), p= 0.034.

Multivariate analysis revealed patients with pre-existing CKD has a higher risk of developing unresolved AKI, RR= 4.221 (95% CI 0.064-0.178). Creatinine level has a RR: 1.030(95%CI 1.007-1.054). Females have a higher tendency towards AKI resolution RR: 2.533(95%CI 0.422-0.053.

Conclusions: This study demonstrates that 21.2% of COVID-19 patients with AKI lead to unresolved AKI. The total workload for 2 million COVID-19 patients in Malaysia can be estimated from our study. 2% of the 2 million patients is of Category 3-5 who are likely to be hospitalised. Out of these, 28% who develops AKI probably would have 21.2% unresolved AKI. Hence, approximately 2262 patients would end up with worsening CKD or new CKD. These groups of patients should be recommended for close monitoring of kidney function once discharged. Prospectively, there will be a need to follow them up with renal profile and urine protein analysis. Early detection of high-risk group especially with premorbid CKD and prompt intervention may improve worsening kidney impairment in our population. The potential disease burden of AKI post COVID-19 can be extrapolated which includes increased demand of health services in our population.

Abbreviations Introduction: SARS-CoV-2 infection, or COVID-19 infection as it is commonly known worldwide, was declared to be a pandemic by the World Health Organization on 11 March 2020. Healthcare workers (HCW) have been on the frontlines in combating this disease since its first discovery. Due to this, it is only logical that HCW face higher risk of COVID-19 infection due to the risk of exposure. This study aims to explore the health-related quality of life (HRQoL) of HCW from the Nephrology and Urology Departments at Hospital Kuala Lumpur (HKL) post COVID-19 infection. Methods: HCW from Nephrology/Urology Departments at HKL who had COVID-19 infection between 1 January to 31 August 2021 were identified. They were invited to answer an online questionnaire via Google Forms. Participants were informed of the objective of the questionnaire and their responses were kept anonymous. Demographic data and post COVID-19 symptoms information were collected. The 36-Item Health Survey (SF-36) was used to assess each participant's HRQoL scores. The SF-36 mean scores for eight specific sections of the questionnaire were compared to the Malaysian population norm group. Results: A total of 92 responses were received. 20 participants (21.7%) were male, and 72 participants (78.3%) were female. Each item in the SF-36 questionnaire was scored on a 0 to 100 range. A high score defined a more favourable state of health. The SF-36 was divided into 8 subscales: (1) physical function (PF), (2) limitations due to physical health problems (role physical, RP), (3) bodily pain (BP), (4) general health (GH), (5) vitality (VT), (6) social functioning (SF), (7) limitations due to emotional health problems (role emotional, RE), and (8) mental health. PF, RP and BP focused on physical health status while RE, MH and SF scales focused on mental health. VT and GH were sensitive to both physical and mental health outcomes.

In this study, there was significant reduction in the scores of almost all the components of the SF-36 questionnaire, namely physical function (meanAESD 73.97AE22.54; p 0.00), role physical ( Introduction: A significant link has been reported between COVID-19 disease and renal dysfunction. This study investigated the prevalence and correlated factors for renal impairment in hospitalized patients with COVID-19 pneumonia Methods: This retrospective study examined medical files of patients with confirmed severe COVID-19 pneumonia that had available serum creatinine results. The outcome variable was renal dysfunction that was defined as increased serum creatinine above the upper limit of normal range (ULNR). Factors significant at 10% level in bivariate analyses were considered in a multivariate logistic regression analysis to produce adjusted odds ratios and their 95% confidence intervals. Results: In total, 179 patients were included in the study and the mean age was 58 years (SD 16.5) and 49% were female. The main admission comorbidities were hypertension (50.0%), diabetes mellitus (28.6%), HIV/AIDs (21.9%) and chronic kidney disease (7.6%). Introduction: Determination of markers of severe COVID-19 is critical in identifying patients who need intensive monitoring and for efficient allocation of hospital resources. Urinalysis is an inexpensive, noninvasive, and readily available test that could potentially identify patients with severe type of COVID-19 infection.

Methods: This was a retrospective study and patients >18 years old who tested positive for COVID-19 by RT-PCR with no history of chronic kidney disease were eligible for participation. The subjects were grouped depending on COVID-19 disease severity (moderate, severe, or critical). Patients' data including co-morbidities, baseline serum creatinine, BUN and urinalysis were collected and recorded. Descriptive analysis, t-test for two means and two proportions, analysis of variance and Chi-square were used for data analysis.

Results: A total of 283 patients underwent screening and 221 subjects were enrolled in the study. One hundred seventeen (53%) were moderate, 94 (43%) were severe and 10 (4%) were critical patients. The mean age of moderate patients was 52, severe 57, and critical 61 years. There was no significant difference between disease severity and age and sex. Patients >65 years old presented commonly (53%) with severe disease. Hypertension as co-morbidity was common in the severe (51%) and critical (60%) groups. Diabetes was common in the severe (37%) and critical (30%). Bronchial asthma is present in 6% of subjects in the severe group and 70% of critical patients have other comorbidities (hyperthyroidism, obesity, cerebrovascular accident, pulmonary tuberculosis, coronary artery disease, chronic obstructive pulmonary disease, heart failure, gouty arthritis, and malignancy). The moderate group presented with a baseline creatinine of 92.71AE37.65. The baseline creatinine of severe (108.7AE70.84) and critical (143.79AE82.67) patients were significantly higher (p=.008), with a difference of 17% and 55% respectively compared to the moderate group. Mean baseline BUN was elevated only in the critical group (10.59AE9.84).

The majority (73.5%) of the moderate group presented with no proteinuria. Proteinuria was present in the severe (57%) and critical groups (90%). More severe degree of proteinuria (more than +2 proteinuria) was noted in 30% of the critical group. The mean urine RBC count was noted to be 8 fold higher in the severe (225.99AE724) and critical group (19870) as compared to the moderate group (27.86AE192). Urine WBC was also significantly different, The mean urine WBC in the moderate was still in the normal range (25.96), in the severe group there is doubling (61.83) and up to 1000.5 in the critical group. Among those who recovered, only 4.1% had proteinuria as compared to 42% of patients who expired. Higher mean RBC and WBC were also noted among those who died of the disease.

Conclusions: Baseline serum creatinine, BUN, proteinuria, hematuria, and urine WBC were significantly higher among those with severe and critical COVID-19. Abnormal urinalysis result (proteinuria, hematuria, and urine WBC) were common among those who died of COVID-19. In conclusion, abnormal urinalysis is a predictor of severe and critical COVID-19. There was no significant difference between the severity of COVID-19 infection and patients' age and sex. Hypertension, diabetes and other co-morbidities were common among those with severe and critical COVID-19 infection. Methods: This is a retrospective study in a tertiary hospital for patients who required intensive care due to COVID-19 infection in northeast Brazil. Patients with RT-PCR confirmed for COVID-19 had electronic medical records evaluated. Two distinct groups according with epidemiologic data were constructed: first or second wave group (2020 and 2021, respectively). The severity of patients admitted to the ICU was estimated using the SAPS 3 score. Results: A total of 767 patients were included: 290 were enrolled in the first wave and 477 in second wave. Patients in the first wave presented more comorbidities, excepted non-dialytic chronic kidney disease (CKD) and morbid obesity, they were put on mechanical ventilation more frequently, and also required vasopressors and dialysis more frequently (p<0.05). During the second wave, non-invasive ventilation was more often required (p<0.05). In both periods, older patients and higher SAPS 3 score on admission were associated with death (p<0.05).

Pinheiro Dantas, MM 3

University of Fortaleza, Public Health Graduate Program

Fortaleza, Brazil, 4 Federal University of Ceara